| Trial ID: | L6218 |
| Source ID: | NCT03208309
|
| Associated Drug: |
Diacerein
|
| Title: |
Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Complications of Diabetes Mellitus|Diabetes Mellitus|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Diacerein|DRUG: Placebo
|
| Outcome Measures: |
Primary: Fasting Glucose, 4 weeks|HbA1c - glycated haemoglobin, 12 weeks|Cholesterol, 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: ANS Pharma | Collaborators: University of Campinas, Brazil|Conselho Nacional de Desenvolvimento Científico e Tecnológico
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-01
|
| Completion Date: |
2015-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-07-05
|
| Locations: |
Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil|Centro de Estudos em Diabetes e Hipertensão, Fortaleza, Ceará, Brazil|Universidade Estadual de Campinas, Campinas, São Paulo, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT03208309
|
